In order to stop the spread of COVID-19, there is an urgent need for business, government and academia to overcome existing barriers and join forces, free from established mindsets, to accelerate development and manufacturing in such fields as therapeutic drugs, vaccines, medical devices and infection control products.

CIOs should immediately establish what aspects of their current spend can be deferred, eliminated or altered. Attention should be focused on spend that is not yet incurred or committed and is nonessential/discretionary and variable in nature.

As the COVID-19 coronavirus continues to spread, the topic is being used in many malicious campaigns — including email spam, business email compromise (BEC), malware, ransomware, and malicious domains. Fraud activity is still on the rise as communities remain in quarantine.

Amazon is extending the pay increase it announced in March, […]

To address regional customer challenges related to budget constraints and making remote working more secure, CyberKnight has launched a special CSR program which offers a range of cybersecurity solutions at no cost, in collaboration with its vendors.